In these tumour contexts, IL-22, locally released together with IL-17 by tumor-infiltrating lymphocytes (TILs), promotes epithelial carcinogenesis, since it activates proliferation and migration of transformed keratinocytes, as well as the expression of inflammatory and anti-apoptotic molecules which contribute to tumor progression [10, 12]. The gene discussed is IL22; the disease is neoplasm.